Literature DB >> 12052276

Clinical trials of treatments for stroke.

John Blass1.   

Abstract

The "gold standard" for therapeutic trials is the prospective, double-blind, placebo-controlled, multicenter trial. However, they are relatively clumsy instruments for discovering innovative new treatments. This article briefly reviews selected clinical trials of treatments for stroke, including stroke rehabilitation, published during 2001 and the first 2 months of 2002. It also reviews other types of studies, including close observations of single patients, which can have a valuable role in generating useful new knowledge.

Entities:  

Mesh:

Year:  2002        PMID: 12052276     DOI: 10.1007/s11883-002-0004-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  17 in total

1.  A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke.

Authors:  L Sonde; M Nordström; C G Nilsson; J Lökk; M Viitanen
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

2.  Suicidal ideation related to fluoxetine treatment.

Authors:  P Masand; S Gupta; M Dewan
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

3.  Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.

Authors:  U Junghans; R J Seitz; A Aulich; H J Freund; M Siebler
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

4.  Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study.

Authors:  D van Dijk; A P Nierich; E W Jansen; H M Nathoe; W J Suyker; J C Diephuis; W J van Boven; C Borst; E Buskens; D E Grobbee; E O Robles De Medina; P P de Jaegere
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

5.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

Authors:  J P Mohr; J L Thompson; R M Lazar; B Levin; R L Sacco; K L Furie; J P Kistler; G W Albers; L C Pettigrew; H P Adams; C M Jackson; P Pullicino
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

Review 6.  Oral contraceptives: current status.

Authors:  R T Burkman
Journal:  Clin Obstet Gynecol       Date:  2001-03       Impact factor: 2.190

7.  Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial.

Authors: 
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Comparing stroke rehabilitation outcomes between acute inpatient and nonintense home settings.

Authors:  F Ozdemir; M Birtane; R Tabatabaei; S Kokino; G Ekuklu
Journal:  Arch Phys Med Rehabil       Date:  2001-10       Impact factor: 3.966

9.  Extending tissue plasminogen activator use to community and rural stroke patients.

Authors:  José G Merino; Brian Silver; Edward Wong; Blaine Foell; Bart Demaerschalk; Arturo Tamayo; Fali Poncha; Vladimir Hachinski
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

10.  Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital.

Authors:  W H Brooks; R R McClure; M R Jones; T C Coleman; L Breathitt
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.